To study the dermoscopic finding of Vitiligo to assess the disease activity.
Not Applicable
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2020/11/028930
- Lead Sponsor
- Manal Dave
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All clinically diagnosed cases of vitiligo including patients on treatment.
Exclusion Criteria
Patient with Vitiligo Universalis.
Patient with depigmentation by other disorder, chemical or burns diagnosed clinically or any other suspected cause of leucoderma by patientâ??s history.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ï??To assess and compare the dermoscopic findings according to the given parameters in the patients of stable and unstable vitiligo.Timepoint: Study will be conducted from Oct 2020 to Sept 2021
- Secondary Outcome Measures
Name Time Method ï??To study any new finding if found in the patient of vitiligo. <br/ ><br>ï??To assess the dermoscopic finding in the lesion of vitiligo after treatment. <br/ ><br>Timepoint: Study will be conducted from Oct 2020 to Sept 2021